欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是

中国临床药理学与治疗学 ›› 2000, Vol. 5 ›› Issue (2): 138-141.

• 论著 • 上一篇    下一篇

盐酸乙哌立松颗粒剂人体生物利用度研究

郭瑞臣, 王本杰, 张文东, 李朝武, 李智立1   

  1. 山东医科大学附属医院, 济南 250012;
    1中国兵器工业第53 研究所, 济南 250031
  • 收稿日期:2000-03-12 修回日期:2000-04-10 出版日期:2000-06-26 发布日期:2020-12-01
  • 作者简介:郭瑞臣, 男, 43岁, 山东医科大学临床药理研究所副主任、主任药师、教授、硕士研究生导师, 研究方向为临床药学和临床药理学。

Relative bioavalability of hydrochloride eperisone granule in healthy volunteers

GUO Rui-Chen, WANG Ben-Jie, ZHANG Wen-Dong, LI Chao-Wu, LI Zhi-Li1   

  1. Affiliated Hospital of Shandong Medical University, Jinan, 250012; 1Institute 53 of China's Ordnance Industry, Jinan, 250031
  • Received:2000-03-12 Revised:2000-04-10 Online:2000-06-26 Published:2020-12-01

摘要: 目的 比较盐酸乙哌立松颗粒剂与国外同类产品(妙纳片)的生物等效性。方法 10名志愿者单剂双交叉一次口服盐酸乙哌立松颗粒剂或妙纳片150mg,肘静脉采血,以托哌酮为内标,采用GC-MS法测定各志愿者经时血浓度,计算主要药代动力学参数,并进行制剂间、个体间、阶段间双单侧t检验和(1-2α)置信区间分析。结果 两制剂血药浓度-时间数据经3p87药代动力学计算程序拟合,符合二室模型,实验制剂和参比制剂AUC0-8分别为(17.9±1.2)和(18.6±1.6)ng·h·ml-1,AUC0-∞分别为(19.1±1.2)和(20.2±1.6)ng·h·ml-1,Cmax分别为(5.2±0.5)和(5.4±0.5)ng·ml-1,Tpeak分别为(1.05±0.18)和(1.08±0.23)h,t1/2(α)分别为(0.78±0.13)和(0.82±0.15)h,t1/2(β)分别为(1.8±0.3)和(1.8±0.3)h。盐酸乙哌立松颗粒剂相对生物利用度为(105±5)%。结论 盐酸乙哌立松颗粒剂与妙纳片药代动力学参数剂型间、个体间、阶段间无显著性差异(P>0.05),两制剂具有生物等效性。

关键词: 盐酸乙哌立松颗粒剂, 妙纳片, 生物利用度, 生物等效性, GC-MS, 托哌酮

Abstract: Aim Therelative bio avalability of hydrochloride eperisone granule in 10 healthy volunteers was studied.Methods The time-p lasma concentrations of hydrochloride eperisone granule, as test drug, and my onal, as reference drug, weredetermined by GC-MS, with tolperisone senuingas internal standard.The pharmacokinetic parameters of both reference and test drug werecalculated and analyzed with two-one side test and confidential intervaltest.Results Theresults showed that the AUC0-8, AUC0-∞, Cmax, Tpeak, t1/2 (α)and t1/2(β) were(17.9±1.3)ng·h·ml-1 and(18.6±1.6)ng·h·ml-1, (19.1±1.2)ng·h·ml-1 and (20.2±1.6)ng·h·ml-1, (5.2±0.5)ng·ml-1 and (5.4±0.5)ng·ml-1, (1.05±0.18)h and (1.08±0.23)h, (0.78±0.13)h and (0.82±0.14)h, (1.8±0.3)h and (1.8±0.3)h, respectively.Therelative bioavalability of test drug was (105±5)%.Conclusion I t can be concluded that the test and reference arebioequivalented be tween individuals, preparations and periods.

Key words: eperisone hydrochloride, myonal, bioavalability, bioequivalence, GC-MS, tolperisong

中图分类号: